<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="retraction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2024.1392563</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: CSF p-tau as a potential cognition impairment biomarker in ALS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/228891/overview"/>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="edited-by"><p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Frontiers Editorial Office <email>research.integrity&#x00040;frontiersin.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1392563</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front. Neurol." journal-id-type="nlm-ta" vol="13" page="991143" xlink:href="10.3389/fneur.2022.991143" ext-link-type="doi">A Retraction of the Original Research Article <article-title>CSF p-tau as a potential cognition impairment biomarker in ALS</article-title> by Gong, Z., Gao, L., Lu, Y., and Wang, Z. (2022). <italic>Front. Neurol</italic>. 13:991143. doi: <object-id>10.3389/fneur.2022.991143</object-id></related-article>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="317"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Dementia and Neurodegenerative Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The journal retracts the 01 November 2022 article cited above.</p>
<p>Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data during the investigation, which was conducted in accordance with Frontiers&#x00027; policies. Given the lack of raw data, the editors no longer have confidence in the findings presented. The article is therefore retracted.</p>
<p>This retraction was approved by the Chief Editors of Frontiers in Neurology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.</p>
<p>Frontiers would like to thank the concerned reader who contacted us regarding the published article.</p>
</body>
</article>